CODE OF
This is an online Blog book to discuss our patients deidentified health data shared after taking his/ her guardians to sign an informed consent
Here we discuss our patient problems through a series of inputs from the available Global online community of experts with n aim to solve those patient clinical problems with the current best evidence-based input
This Blog also reflects my patient-centred online learning portfolio.
Your valuable input on the comment box is welcome
I have been given this case to solve in an attempt to understand the topic of " Patient clinical data analysis" to develop my competence in reading and comprehending clinical data including history, clinical findings, and investigations and coming up with a diagnosis and treatment plan.
DEIDENTIFIED DISCHARGE SUMMARY:
Age/Gender 66 Years/Male
Address
Discharge Type: Relleved
Admission Date: 04/11/2022 06:08 PM
Diagnosis
CKD ON MHD
Case History and Clinical Findings
CHIEF COMPLAINTS:
C/O BIL PEDAL EDEMA SINCE 1 WEEK
HOPI:
THE PATIENT WAS APPARENTLY ASYMPTOMATIC 1 WEEK, THEN DE VELOPEDBIL PEDAL EDEMA PITTING TYPE AND ALSO DEVELOPED SOB AND DECREASED URINE OUTPUT 1 WEEK BACK
PAST HISTORY:
NOT A KICIO DM, TB, ASTHMA, EPILEPSY
GENERAL EXAMINATION,
PATIENT WAS CONSCIOUS, COHERENT, COOPERATIVE
VITALS
TEMPERATURE AFEBRILE
BP 150/70 mmHg
HR: 96 BPM
SPO2: 96% ON RA
GRBS 110 Mg/dl
CVS S1,S2
RS CLEAR, BΑΕ
CNS INTACT
PIA SOFT, NONTENDER
BS+
2D ECHO:
MILD CONCENTRIC LVH
NO RWMA
EF 63%
DILATED LA AND LV
NO PE
TRIVIAL TR, MILD MR, MILD AR
GOOD LV SYSTOLIC FUNCTION
GRADE I DIASTOLIC DYSFUNCTION
Investigation
CBP
HB 8.8
TC 6500
PLT 1.67
SMEAR NORMOCYTIC NORMOCHROMIC
RFT
UR 56
CR3.2
CA+29.5
P2.5
NA+ 145
K+40
CL-105
HIV NEGATIVE
HBSAG NEGATIVE
HCV NEGATIVE
CUE YELLOW IN COLOUR
ALBUMIN++
SUGAR+
PUS CELSS 2-3
EPI CELLS 2-3
NO RBC
SR. Fe 83
TB 0.76
DB 0.18
AST 23
ALT 17
ALP 155
TP 6.4
ALB 3.5
USG: B/L GRADE III RPD CHANGES
Treatment Given (Enter only Generic Name)
1 TAB LASIX 80 MG/BD
2T OROFER XT OD
4T SHELCAL 500 MG/OD
5 CAP BIO D3/00
6T NICARDIA 20MG/TID
7T MET XL 25 MG/OD
8 INJ EPI 400 IU/BI WEEKLY
9 INJ IRON SUCROSE 100MG/BIWEEKLY
Advice at Discharge
1 TAB LASX 80 MG/BD
2 T OROFER XT/OD
4 T SHELCAL 500 MG/OD
5 CAP BIO D3/dD
6.T NICARDIA 20MG/TID
7 T MET XL 25 MG/OD
8 INI, EPI 400 IU/BI WEEKLY
9 INU IRON SUCROSE 100MG/BI WEEKLY
Follow Up
VISIT FOR DIALYSIS THRICE WEEKLY
When to Obtain Urgent Care
IN CASE OF ANY EMERGENCY IMMEDIATELY CONTACT YOUR CONSULTANT DOCTOR OR
ATTEND EMERGENCY DEPARTMENT
Preventive CareAVOID SELF MEDICATION WITHOUT DOCTORS ADMCE DONOT MISS MEDICATIONS. In case of Emergency or to speak to your treating FACULTY or For Appointments, Please Contact: 08682279999 For Treatment Enquiries Patient/Attendent Declaration: The medicines prescribed and the advice regarding preventive aspects of care when and how to obtain urgerit care have been explained to me in my own language
SIGNATURE OF PATIENT ATTENDER
SIGNATURE OF PG/INTERNEE
SIGNATURE OF ADMINISTRATOR
SIGNATURE OF FACULTY
Discharge Date
Date: 21/12/22
Ward NEPHROLOGY
CASE REPORT:
66 year male, farmer, Resident of Nalgonda who was apparently asymptomatic 30 years ago, on routine checkup diagnosed with diabetes and using OHA's; he had a alleged history of RTA causing fracture to right femur. Patient sought for consultation and was advised for surgical management and was diagnosed with Hypertensionand started on medications, he got scared and didn't visited doctor again and went for (kattu mandu) stabilization with wooden sticks and started using pain killers for the pain for 3 years. His pain gradually decreased, but not subcided. After 6 months, he started walking with stick in one hand. 5 years ago had complaints of generalized body pains for which he sought for consultation at local hospital, and on routine workup, he was diagnosed with renal failure, started on conservative management and stopped OHAs and started on Insulin therapy. After 2 years he had complaints of generalized itching, bilateral pedal edema till knees, decreased appatite, nausea, breathlessness and sought for consultation; and initated on hemodialysis. After 7 months of hemodialysis patient started having complaints of Breathlessness on exertion which was progressed to breathlessness on less than normal physical activity gradually over 4 months. He was changed the visit to dialysis from once weekly to twice weekly. After 1 1/2 year, his complaints of Breathlessness and pedal edema increased and has 3 episodes of acute pulmonary edema due to delayed visits for dialysis (overload); patient was advised for thrice weekly hemodialysis sessions.
Laboratory parameters:
1st Assesment:
Hb (gm/dl) 8.8 (NCNC)
BLOOD UREA (mg/dl) 56
Sr.CREATININE (mg/dl) 8
eGFR (ml/min/1.72m²) 21 (IV)
Sr.Na+ (mEq/L) 143
Sr.K+ (mEq/L) 4.0
Sr.Cl- (mEq/L) 105
Sr. Ca+2 (mEq/L) 9.5
Sr. Phosphorus (mEq/L) 2.5
TOTAL BILIRUBIN (mg/dl) 0.76
DIRECT BILIRUBIN (mg/dl) 0.18
AST/SGOT (IU/L) 23
ALT/SGPT (IU/L) 17
ALP (IU/L) 155
TOTAL PROTEINS (gm/dl) 6.5
Sr.ALBUMIN (gm/dl) 3.5
CUE ALBUMIN +2, SUGARS +1
Sr. Fe (mcg/dl) 83
Usg
RIGHT kidney 7.2x 3.1cms ,CMD LOST
LEFT kidney 7.8 x 4.2 cms, CMD LOST
IMPRESSION B/L GRADE 3 RPD CHANGES
2D ECHO -
At first assessment
EF - 63%
Mild concentric LVH (1.24cms)
Dilated LV & LA
Good LV systolic function
Grade I diastolic dysfunction
No RWMA
No Pericardial effusion
Mild MR, Mild AR, Trivial TR
RVSP= 32mmHg
HFA-PEFF Score =3 points.
Management:
1. Fluid restriction <1.5 lit/day.
2. Salt restriction of < 2 g/day
3. TAB. FUROSEMIDE 80 MG/BD
4. TAB. NIFEDIPINE 20 mg/ TID
5. TAB. METAPROLOL 25 MG/ BD
6. TAB. OROFER XT OD
7. TAB. SHELCAL 500 MG/OD
8. CAP. BIO D3/0D
9. INJ IRON SUCROSE 100MG/BIWEEKLY
10. INJ EPI 400 IU/BI WEEKLY
Follow up assessment:
Hb (gm/dl) 8.8 (NCNC)
BLOOD UREA (mg/dl) 67
Sr.CREATININE (mg/dl) 3.6
eGFR (ml/min/1.72m²) 10 (Stage V)
Sr.Na+ (mEq/L) 145
Sr.K+ (mEq/L) 3.6
Sr.Cl- (mEq/L) 99
Sr. Ca+2 (mEq/L) 10.1
Sr. Phosphorus (mEq/L) 3.8
TOTAL BILIRUBIN (mg/dl) 1.19
DIRECT BILIRUBIN (mg/dl) 0.24
AST/SGOT (IU/L) 22
ALT/SGPT (IU/L) 23
ALP (IU/L) 168
TOTAL PROTEINS (gm/dl) 5.7
Sr.ALBUMIN (gm/dl) 3.2
CUE ALBUMIN +2, SUGARS trace
Sr. Fe (mcg/dl) 70
2D ECHO
Follow up assesment:
EF - 52%
Mild concentric LVH
All chambers dilated
Good systolic function
Grade II diastolic dysfunction
No RWMA
Minimal Pericardial effusion
Mild MR, mild AR, mild TR
MANAGEMENT:
1. Fluid restriction <1.5 lit/day.
2. Salt restriction of < 2 g/day
3. TAB. FUROSEMIDE 80 MG/BD
4. TAB. NIFEDIPINE 20 mg/ TID
5. TAB. METAPROLOL 25 MG/ BD
6. TAB. CLONIDINE 0.1 MG/ TID
7. TAB. SHELCAL CT 500 MG/OD
8. TAB. OROFER XT OD
9. INJ IRON SUCROSE 100MG/BIWEEKLY
10. INJ EPI 400 IU/BI WEEKLY
11. DIALYSIS ALTERNATE DAY
OUTCOMES:
INTRA-DIALYTIC HYPOTENSION: NO
POST-DIALYTIC HYPOTENSION: NO
HYPOTENSION REQUIRING IONOTROPIC SUPPORT: NO
ACUTE CARDIOGENIC PULMONARY: YES
ISCHEMIC HEART DISEASE: NO
EMERGENCY HOSPITALIZATION: YES
MORTALITY: YES
Comments
Post a Comment